US502504A
(en)
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
*
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US1792158A
(en)
|
1930-04-24 |
1931-02-10 |
Robert H Gleckner |
Belt
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2048375A
(en)
|
1935-07-06 |
1936-07-21 |
Edison Splitdorf Corp |
Magneto-electric generator
|
US2288422A
(en)
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
DE925476C
(de)
|
1950-04-29 |
1955-03-21 |
Variapat Ag |
Verfahren zur Herstellung von farblosen, wasserloeslichen, trifluormethyl- und sulfonsaeuregruppenhaltigen, aliphatischen oder aromatischen Carbonsaeure- bzw. Sulfonsaeurearyliden
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
BE527017A
(da)
|
1953-03-06 |
|
|
|
US2745874A
(en)
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
NL193403A
(da)
|
1953-12-22 |
1924-02-17 |
|
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(da)
|
1959-08-14 |
|
|
|
NL277511A
(da)
|
1961-04-21 |
|
|
|
US3177110A
(en)
|
1961-07-24 |
1965-04-06 |
Aschaffenburger Zellstoffwerke |
Process for pretreating wood for the production of cellulose
|
CH479557A
(de)
|
1961-09-11 |
1969-10-15 |
Wander Ag Dr A |
Verfahren zur Herstellung neuer mehrbasischer Verbindungen
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(da)
|
1965-06-09 |
1968-02-21 |
|
|
US3424760A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424762A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3424761A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
SE370866B
(da)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
*
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3646059A
(en)
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3668222A
(en)
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
JPS5031039A
(da)
|
1973-07-27 |
1975-03-27 |
|
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
US4116671A
(en)
|
1973-07-27 |
1978-09-26 |
Shionogi & Co., Ltd. |
3-Isoxazolylcarbamate derivatives
|
US4001256A
(en)
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4071524A
(en)
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4410697A
(en)
|
1980-01-25 |
1983-10-18 |
Reanal Finomvegyszergyar |
Process for the preparation of N-aryl-N'-(mono- or di substituted)-urea derivatives
|
DE3174885D1
(en)
|
1981-02-03 |
1986-07-31 |
Ici Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
DE3211851A1
(de)
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
AU1862083A
(en)
|
1982-09-02 |
1984-03-08 |
Duphar International Research B.V. |
Tumor growth inhibitors
|
CA1254212A
(en)
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
*
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
EP0255297B1
(en)
|
1986-07-31 |
1993-04-21 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation, and their pharmaceutical use
|
NZ221964A
(en)
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
EP0264904A3
(en)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Pharmaceutical compositions containing benzoyl urea derivatives
|
DE3636190A1
(de)
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
DD253997A1
(de)
|
1986-11-26 |
1988-02-10 |
Karl Marx Uni Buero Fuer Neuer |
Verfahren zur herstellung von substituierten 2-arylureidophenolen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
ES2070861T3
(es)
|
1987-10-16 |
1995-06-16 |
Ciba Geigy Ag |
Compuestos antiparasitarios.
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
AU636853B2
(en)
|
1988-08-23 |
1993-05-13 |
Nutrasweet Company, The |
Substituted aryl ureas as high potency sweeteners
|
EP0359146B1
(en)
|
1988-09-08 |
1994-08-03 |
Dainippon Ink And Chemicals, Inc. |
Liquid crystal device
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
JP3002204B2
(ja)
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
US5177110A
(en)
*
|
1989-10-27 |
1993-01-05 |
Ciba-Geigy Corporation |
Injectable parasiticidal composition
|
NZ238624A
(en)
|
1990-06-19 |
1994-08-26 |
Meiji Seika Co |
Pyridine derivatives, compositions, preparations and use thereof
|
DE4022720A1
(de)
|
1990-07-17 |
1992-01-23 |
Flohe Gmbh & Co |
Untergefaess eines gleichstromlichtbogenofens
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
ATE157355T1
(de)
|
1991-01-21 |
1997-09-15 |
Shionogi & Co |
3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
|
JP2671693B2
(ja)
|
1991-03-04 |
1997-10-29 |
松下電器産業株式会社 |
バイオセンサおよびその製造法
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
JPH05112573A
(ja)
|
1991-04-17 |
1993-05-07 |
American Home Prod Corp |
ラパマイシンのカルバミン酸エステル類
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5721237A
(en)
*
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
US5185358A
(en)
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
AU2552492A
(en)
|
1991-08-23 |
1993-03-16 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
EP0630373A1
(en)
|
1992-03-12 |
1994-12-28 |
Smithkline Beecham Plc |
Indole derivatives as 5ht1c antagonists
|
SK142694A3
(en)
|
1992-05-28 |
1995-06-07 |
Pfizer |
N-aryl and n-heteroarylurea derivatives as inhibitors of acylcoenzyme a:cholesterol-acyltransferase, pharmaceutical preparations contains these compounds and use
|
JPH0625221A
(ja)
|
1992-07-10 |
1994-02-01 |
Tokuyama Soda Co Ltd |
3−アミノ−2−チオフェンカルボン酸誘導体の製造方法
|
US5312820A
(en)
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
ZA935112B
(en)
|
1992-07-17 |
1994-02-08 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
ZA935111B
(en)
|
1992-07-17 |
1994-02-04 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
CA2140653A1
(en)
|
1992-08-12 |
1994-03-03 |
Irene Abraham |
Protein kinase inhibitors and related compounds combined with taxol
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
DE4227989A1
(de)
|
1992-08-21 |
1994-06-09 |
Schering Ag |
Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
CN2146707Y
(zh)
|
1992-09-08 |
1993-11-17 |
华东冶金学院 |
高炉软水冷却***检漏装置
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
CN2148707Y
(zh)
|
1992-12-15 |
1993-12-08 |
高英郎 |
螺丝固定的雨刷的接头改进装置
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(da)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
AU6633694A
(en)
|
1993-04-09 |
1994-11-08 |
Board Of Regents Of The University Of Nebraska, The |
Novel methods and compositions for the treatment of (ras)-activated cancer with heterotypic anti-(raf) antisense oligonucleotides
|
GB9308802D0
(en)
|
1993-04-28 |
1993-06-09 |
Smithkline Beecham Plc |
Treatment
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US5378725A
(en)
*
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
US6514745B1
(en)
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
NZ264063A
(en)
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
NZ274063A
(en)
|
1993-09-17 |
1997-11-24 |
Smithkline Beecham Corp |
Cytokine suppressive anti-inflammatory drug binding protein (csbp) and its use
|
US6361773B1
(en)
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(en)
*
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
US5596001A
(en)
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
EP1306377A3
(en)
|
1993-11-08 |
2003-05-07 |
Smithkline Beecham Corporation |
Pyridyl-oxazoles and their use as cytokines inhibitors
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
WO1995014023A1
(en)
|
1993-11-19 |
1995-05-26 |
Abbott Laboratories |
Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
|
SG64372A1
(en)
|
1993-12-17 |
1999-04-27 |
Novartis Ag |
Rapamycin derivatives
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
CA2146495C
(en)
*
|
1994-04-08 |
2006-06-27 |
Len C. Decandia |
Method for making an elastic adhesive bandage
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
WO1995033458A1
(en)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
US5480906A
(en)
*
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
JPH10510512A
(ja)
|
1994-10-04 |
1998-10-13 |
藤沢薬品工業株式会社 |
尿素誘導体とacat阻害剤としての用途
|
ATE220661T1
(de)
|
1994-10-19 |
2002-08-15 |
Novartis Erfind Verwalt Gmbh |
Antivirale ether von aspartat-protease-substrat- isosteren
|
CA2161376C
(en)
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
JP3591938B2
(ja)
|
1994-10-27 |
2004-11-24 |
キヤノン株式会社 |
インクジェット用記録媒体及びこれを用いた画像形成方法
|
WO1996013632A1
(en)
|
1994-10-28 |
1996-05-09 |
Novo Nordisk A/S |
A process for chemical finishing of insoluble polymers
|
TW313568B
(da)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
FR2733324B1
(fr)
|
1995-04-19 |
1997-05-30 |
Schlumberger Ind Sa |
Procede et equipement de test automatique en parallele de composants electroniques
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
IL118544A
(en)
|
1995-06-07 |
2001-08-08 |
Smithkline Beecham Corp |
History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
WO1996041807A1
(en)
|
1995-06-09 |
1996-12-27 |
Novartis Ag |
Rapamycin derivatives
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
CZ272296A3
(en)
|
1995-09-18 |
1997-04-16 |
Sankyo Co |
Novel derivatives of urea exhibiting acat inhibition activity, their preparation and therapeutic and prophylactic application
|
US6075040A
(en)
|
1996-09-05 |
2000-06-13 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
EP0860433B1
(en)
|
1995-11-07 |
2002-07-03 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
|
US6005112A
(en)
|
1995-12-28 |
1999-12-21 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Process for producing pyridinecarboxamides or thiocarboxamides
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6211373B1
(en)
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
US5891895A
(en)
|
1996-04-15 |
1999-04-06 |
Takeda Chemical Industries, Ltd. |
Hydroxypyridine derivatives their production and use
|
CZ298463B6
(cs)
|
1996-04-23 |
2007-10-10 |
Vertex Pharmaceuticals Incorporated |
Deriváty mocoviny pro použití jako inhibitory IMPDH enzymu a farmaceutické prostredky, které je obsahují
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
JP4073489B2
(ja)
|
1996-05-24 |
2008-04-09 |
ニューロサーチ・アクティーゼルスカブ |
酸性基を有するフエニル誘導体、その製造方法及びそれをクロライドチャンネル遮断剤として使用する方法
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
IL127667A0
(en)
|
1996-06-27 |
1999-10-28 |
Smithkline Beecham Corp |
IL-8 receptor antagonists
|
JP2000513360A
(ja)
|
1996-06-27 |
2000-10-10 |
スミスクライン・ビーチャム・コーポレイション |
Il―8レセプターアンタゴニスト
|
WO1997049399A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
EP0912505A4
(en)
|
1996-06-27 |
2001-10-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
WO1998017207A1
(en)
|
1996-10-21 |
1998-04-30 |
Synthes Ag Chur |
Surgical prosthetic device
|
AU4988997A
(en)
|
1996-10-23 |
1998-05-15 |
Osteoscreen, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
JP2001503775A
(ja)
|
1996-11-15 |
2001-03-21 |
ザ ピコワー インスティテュート フォー メディカル リサーチ |
T細胞の活性化に関係する疾患を治療するために有用なグアニルヒドラゾン
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
WO1998022432A1
(fr)
|
1996-11-18 |
1998-05-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derives d'acylanilide a substitution acylamino ou composition comprenant ces derives
|
FR2755967B1
(fr)
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
JP2001511130A
(ja)
|
1997-01-23 |
2001-08-07 |
スミスクライン・ビーチャム・コーポレイション |
Il−8受容体アンタゴニスト
|
US5929250A
(en)
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
EP0971908B1
(en)
|
1997-02-12 |
2004-06-30 |
SmithKline Beecham Corporation |
Il-8 receptor antagonists
|
US20020111495A1
(en)
|
1997-04-04 |
2002-08-15 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
BR9810733A
(pt)
|
1997-04-04 |
2000-09-12 |
Pfizer Prod Inc |
Derivados de nicotinamida
|
DE69811062T2
(de)
|
1997-04-10 |
2003-07-17 |
Upjohn Co |
Polyaromatische antivirale zusammensetzungen
|
AU7080298A
(en)
|
1997-04-25 |
1998-11-24 |
Takeda Chemical Industries Ltd. |
Triazine derivatives, their production and agrochemical composition
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
IL132736A0
(en)
|
1997-05-22 |
2001-03-19 |
Searle & Co |
3(5)-Heteroaryl substituted pyrazoles as p38 kinase inhibitors
|
US6087381A
(en)
|
1997-05-22 |
2000-07-11 |
G. D. Searle & Company |
Pyrazole derivatives as p38 kinase inhibitors
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
DE1019040T1
(de)
|
1997-05-23 |
2001-02-08 |
Bayer Ag |
Hemmung von p38 kinase aktivität durch arylharnstoff
|
US6187799B1
(en)
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
US6344476B1
(en)
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
AU7585598A
(en)
|
1997-05-23 |
1998-12-11 |
Bayer Corporation |
Raf kinase inhibitors
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
US5985592A
(en)
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
EP1023066A4
(en)
|
1997-06-13 |
2001-05-23 |
Smithkline Beecham Corp |
NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND
|
US6159901A
(en)
|
1997-06-27 |
2000-12-12 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
6-phenoxy picolinic acid alkylidene hydrazide derivative, process for producing the same and herbicide using the same
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
US6525065B1
(en)
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
AU9802198A
(en)
|
1997-10-21 |
1999-05-10 |
Pharmacia & Upjohn Company |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
SK5462000A3
(en)
|
1997-10-31 |
2001-02-12 |
Aventis Pharma Ltd |
Substituted anilides
|
AU1367599A
(en)
|
1997-11-03 |
1999-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
AU744281B2
(en)
|
1997-11-10 |
2002-02-21 |
Bristol-Myers Squibb Company |
Benzothiazole protein tyrosine kinase inhibitors
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
AU1407899A
(en)
|
1997-12-01 |
1999-06-16 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
US6174901B1
(en)
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
AU1939999A
(en)
*
|
1997-12-22 |
1999-07-12 |
Bayer Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
AU765412B2
(en)
|
1997-12-22 |
2003-09-18 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
DK1043995T3
(da)
|
1997-12-22 |
2007-03-05 |
Bayer Pharmaceuticals Corp |
Inhibering af p38 kinaseaktivitet ved anvendelse af aryl- og heteroaryl-substituerede, heterocykliske urinstoffer
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
IL136738A0
(en)
*
|
1997-12-22 |
2001-06-14 |
Bayer Ag |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
CA2315646C
(en)
*
|
1997-12-22 |
2010-02-09 |
Bayer Corporation |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
HUP0101704A3
(en)
*
|
1997-12-22 |
2002-12-28 |
Bayer Corp Pittsburgh |
Kinease substituted heterocyclic ureas with raf inhibition activity and pharmaceutical compositions containing them
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
WO1999032109A1
(en)
|
1997-12-23 |
1999-07-01 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
EP1043020A1
(en)
|
1997-12-25 |
2000-10-11 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal composition for percutaneous administration
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
EP0975589A2
(en)
|
1998-01-21 |
2000-02-02 |
ZymoGenetics, Inc. |
Dialkyl ureas as calcitonin mimetics
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
ATE238555T1
(de)
|
1998-02-18 |
2003-05-15 |
Theryte Ltd |
Krebsbehandlung
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
AU762245B2
(en)
|
1998-09-18 |
2003-06-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
ID29063A
(id)
|
1998-11-06 |
2001-07-26 |
Basf Ag |
Penghambatan formasi dari hiperpermeabilitas vaskular
|
CA2352486A1
(en)
|
1998-11-25 |
2000-06-02 |
Genetica, Inc. |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
AU3126700A
(en)
|
1998-12-18 |
2000-07-03 |
Du Pont Pharmaceuticals Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
CA2356263C
(en)
|
1998-12-25 |
2009-04-21 |
Teikoku Hormone Mfg. Co., Ltd. |
Aminopyrazole derivatives
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
IL144144A0
(en)
|
1999-01-13 |
2002-05-23 |
Bayer Ag |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
JP3519368B2
(ja)
|
1999-01-22 |
2004-04-12 |
麒麟麦酒株式会社 |
キノリン誘導体およびキナゾリン誘導体
|
WO2000047577A1
(en)
|
1999-02-12 |
2000-08-17 |
Smithkline Beecham Plc |
Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
|
JP2002537397A
(ja)
|
1999-02-22 |
2002-11-05 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症剤としての多環ヘテロ環式誘導体
|
EE04799B1
(et)
|
1999-03-12 |
2007-04-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
|
WO2000055152A1
(en)
|
1999-03-12 |
2000-09-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
EE200100492A
(et)
|
1999-03-19 |
2002-12-16 |
Vertex Pharmaceuticals Incorporated |
Ensüümi IMPDH inhibiitorid
|
AU782353B2
(en)
|
1999-03-26 |
2005-07-21 |
Euro-Celtique S.A. |
Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
DE60009480T2
(de)
|
1999-05-05 |
2005-09-01 |
Aventis Pharma Ltd., West Malling |
Harnstoffe als modulatoren der zelladhäsion
|
JP2003520195A
(ja)
|
1999-05-14 |
2003-07-02 |
イムクローン システムズ インコーポレイティド |
上皮成長因子受容体アンタゴニストによる難治性ヒト腫瘍の処理
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
WO2001004115A2
(en)
|
1999-07-09 |
2001-01-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Novel process for synthesis of heteroaryl-substituted urea compounds
|
AU6314900A
(en)
|
1999-07-26 |
2001-02-13 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
AU6339200A
(en)
|
1999-07-28 |
2001-02-19 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
CA2383626A1
(en)
|
1999-10-15 |
2001-08-02 |
Bobby G. Edwards |
Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
|
US6794393B1
(en)
|
1999-10-19 |
2004-09-21 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6492393B1
(en)
|
1999-11-16 |
2002-12-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
CN1262541C
(zh)
|
1999-12-29 |
2006-07-05 |
惠氏公司 |
三环蛋白激酶抑制剂
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
SK12712002A3
(sk)
|
2000-02-07 |
2003-02-04 |
Abbott Gmbh & Co. Kg |
Deriváty 2-benzotiazolylmočoviny a ich použitie ako inhibítorov proteínkináz
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
US6658473B1
(en)
|
2000-02-25 |
2003-12-02 |
Sun Microsystems, Inc. |
Method and apparatus for distributing load in a computer environment
|
KR20020080461A
(ko)
|
2000-03-02 |
2002-10-23 |
루드빅 인스티튜트 포 캔서 리서치 |
혈관 내피 성장인자 d를 발현하는 암의 치료, 스크리닝,및 검출 방법
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
JP2003525897A
(ja)
|
2000-03-06 |
2003-09-02 |
アストラゼネカ アクチボラグ |
治 療
|
AU2000240570A1
(en)
*
|
2000-03-29 |
2001-10-08 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines as tyrosine kinase inhibitors
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
FR2811670B1
(fr)
|
2000-07-13 |
2004-05-14 |
Rhodia Chimie Sa |
Stabilisation de compositions polymeriques, organosiliciques ou silicone
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
US7175844B2
(en)
|
2000-07-18 |
2007-02-13 |
Joslin Diabetes Center, Inc. |
Methods of modulating fibrosis
|
US6565880B2
(en)
|
2000-07-24 |
2003-05-20 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
EP1355933A2
(en)
|
2000-08-04 |
2003-10-29 |
Loma Linda University Medical Center |
Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases
|
JP4993838B2
(ja)
|
2000-08-11 |
2012-08-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
P38のインヒビターとしてのピリジン誘導体
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
DE60027015T2
(de)
|
2000-08-17 |
2006-10-05 |
The Kitasato Institute |
Pseudoerythromycin-derivate
|
DZ3398A1
(fr)
|
2000-08-31 |
2002-03-07 |
Pfizer Prod Inc |
Derives pyrazole et leur utilisation comme inhibiteurs des proteines kinases
|
AU2001291172A1
(en)
|
2000-09-20 |
2002-04-02 |
The President And Fellows Of Harvard College |
Methods for the diagnosis of neoplastic disorders using angiogenin
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
ES2318649T3
(es)
|
2000-10-20 |
2009-05-01 |
EISAI R&D MANAGEMENT CO., LTD. |
Procedimiento de preparacion de derivados de 4-fenoxi quinolinas.
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
JP2004513935A
(ja)
|
2000-11-17 |
2004-05-13 |
ノボ ノルディスク アクティーゼルスカブ |
グルカゴンアンタゴニスト/逆アゴニスト
|
JP2004513783A
(ja)
|
2000-11-27 |
2004-05-13 |
ブリル,エリック,エー. |
対象物を仕分けるためのシステム、方法及びプログラム
|
NZ525788A
(en)
|
2000-11-28 |
2004-11-26 |
Pfizer Prod Inc |
Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
|
JP2004517080A
(ja)
|
2000-11-29 |
2004-06-10 |
グラクソ グループ リミテッド |
Tie−2および/またはvegfr−2の阻害剤として有用なベンゾイミダゾール誘導体
|
AU2002222589A1
(en)
|
2000-12-08 |
2002-06-18 |
Kyowa Hakko Kogyo Co. Ltd. |
Oral preprations having itching-relievign or antipruritic activity
|
HUP0302526A2
(hu)
|
2000-12-21 |
2003-11-28 |
Glaxo Group Limited |
Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
WO2002059080A2
(en)
|
2001-01-25 |
2002-08-01 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
LT3143995T
(lt)
|
2001-02-19 |
2019-01-25 |
Novartis Ag |
Rapamicino darinys, skirtas plaučių vėžio gydymui
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
ATE366720T1
(de)
|
2001-03-07 |
2007-08-15 |
Telik Inc |
Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
|
DK1370552T3
(da)
|
2001-03-23 |
2007-05-07 |
Bayer Pharmaceuticals Corp |
Rho-kinase-inhibitorer
|
ATE507839T1
(de)
|
2001-04-02 |
2011-05-15 |
Genentech Inc |
Kombinationstherapie
|
MXPA03009361A
(es)
|
2001-04-13 |
2004-01-29 |
Boehringer Ingelheim Pharma |
Compuestos de urea utilies como agentes anti-inflamatorios.
|
MXPA03009000A
(es)
|
2001-04-13 |
2004-02-12 |
Boehringer Ingelheim Pharma |
Compuestos benzo-fusionados 1,4-disustituidos.
|
DE60218445T2
(de)
|
2001-04-20 |
2007-11-29 |
Bayer Pharmaceuticals Corp., West Haven |
Inhibierung der raf-kinase durch chinolin-, isochinolin- oder pyridin-harnstoffe
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US6706711B2
(en)
|
2001-04-27 |
2004-03-16 |
Vertex Pharmaceuticals Incorporated |
Pyrazole derived kinase inhibitor
|
CA2445003A1
(en)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
WO2003004523A1
(en)
|
2001-07-02 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human citron rho/rac-interacting kinase
|
DE60219793T2
(de)
|
2001-07-11 |
2008-01-24 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Verfahren zur Behandlung von Cytokin-Vermittelten Erkrankungen
|
EP1450799B2
(en)
|
2001-12-03 |
2018-07-11 |
Bayer HealthCare LLC |
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
|
JP2005526008A
(ja)
|
2001-12-04 |
2005-09-02 |
オニックス ファーマシューティカルズ,インコーポレイティド |
癌を処置するためのraf−mek−erk経路インヒビター
|
JP4643909B2
(ja)
|
2001-12-21 |
2011-03-02 |
ザ ウェルカム トラスト リミテッド |
遺伝子
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
WO2003060111A2
(en)
|
2001-12-24 |
2003-07-24 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
AU2003207961A1
(en)
|
2002-01-16 |
2003-07-30 |
Ramot At Tel Aviv University Ltd. |
Compositions and their use for enhancing and inhibiting fertilization
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
EP2324825A1
(en)
|
2002-02-11 |
2011-05-25 |
Bayer Healthcare LLC |
Aryl ureas with angiogenesis inhibiting activity
|
US8110587B2
(en)
|
2002-02-11 |
2012-02-07 |
Bayer Healthcare Llc |
Aryl ureas as kinase inhibitors
|
US20040023961A1
(en)
*
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
EP1499311B1
(en)
|
2002-03-29 |
2009-11-04 |
Novartis Vaccines and Diagnostics, Inc. |
Substituted benzazoles and use thereof as raf kinase inhibitors
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
DE10221524A1
(de)
|
2002-05-14 |
2003-12-04 |
Kmb Produktions Ag Felben |
Verfahren und Vorrichtung zum Herstellen von Verzehrgütern
|
AU2003233576A1
(en)
|
2002-05-17 |
2003-12-02 |
Sugen, Inc. |
Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
AU2003246927A1
(en)
|
2002-07-03 |
2004-01-23 |
Astex Technology Limited |
3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
CN1678314A
(zh)
|
2002-08-27 |
2005-10-05 |
默克专利有限公司 |
作为raf-激酶抑制剂的甘氨酸酰胺衍生物
|
WO2004022529A2
(en)
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Diarylurea derivatives and their use as chloride channel blockers
|
RU2005115842A
(ru)
|
2002-10-24 |
2006-03-10 |
Мерк Патент ГмбХ (DE) |
Производные метиленмочевины
|
ES2421516T3
(es)
|
2002-11-06 |
2013-09-03 |
Dana Farber Cancer Inst Inc |
Composiciones para tratar el cáncer usando el inhibidor de proteasomas PS-341
|
KR20050086648A
(ko)
|
2002-11-15 |
2005-08-30 |
노파르티스 아게 |
약물 전달 시스템
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
MXPA05009102A
(es)
|
2003-02-28 |
2006-05-31 |
Bayer Pharmaceuticals Corp |
Derivados de piridina sustituida utiles en el tratamiento del cancer y otros trastornos.
|
CN1839126A
(zh)
|
2003-02-28 |
2006-09-27 |
拜耳制药公司 |
用于治疗癌症和其它病症的新的氰基吡啶衍生物
|
EP1608639A2
(en)
|
2003-02-28 |
2005-12-28 |
Bayer Pharmaceuticals Corporation |
Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
MXPA05010020A
(es)
|
2003-03-24 |
2005-11-17 |
Merck Patent Gmbh |
Derivados de oxamida.
|
WO2004084889A1
(en)
|
2003-03-28 |
2004-10-07 |
Pfizer Inc. |
Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
ATE384264T1
(de)
|
2003-05-20 |
2008-02-15 |
Bayer Pharmaceuticals Corp |
Diaryl-harnstoffe mit kinasehemmender wirkung
|
EP1636210A1
(en)
|
2003-06-05 |
2006-03-22 |
Warner-Lambert Company LLC |
Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
US20070213374A1
(en)
|
2003-07-07 |
2007-09-13 |
Merck Patent Gmbh |
Malonamide Derivatives
|
WO2005005434A1
(en)
|
2003-07-08 |
2005-01-20 |
Novartis Ag |
Use of rapamycin and rapamycin derivatives for the treatment of bone loss
|
WO2005004864A1
(en)
|
2003-07-11 |
2005-01-20 |
Merck Patent Gmbh |
Benzimidazole derivatives as raf kinase inhibitors
|
US7691870B2
(en)
|
2003-07-11 |
2010-04-06 |
Merck Patent Gmbh |
Benzimidazole carboxamides as raf kinase inhibitors
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
WO2005009367A2
(en)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Treatment of diseases with kinase inhibitors
|
NZ580384A
(en)
|
2003-07-23 |
2011-03-31 |
Bayer Pharmaceuticals Corp |
4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
|
AR045134A1
(es)
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
CA2535805A1
(en)
|
2003-08-15 |
2005-02-24 |
University Of Pittsburgh Of The Commnonwealth System Of Higher Education |
Multifactorial assay for cancer detection
|
AU2004273615B2
(en)
|
2003-09-23 |
2009-01-15 |
Novartis Ag |
Combination of a VEGF receptor inhibitor with a chemotherapeutic agent
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
WO2005040100A1
(en)
|
2003-10-15 |
2005-05-06 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene and urea derivatives
|
AU2004281154A1
(en)
|
2003-10-16 |
2005-04-28 |
Novartis Vaccines And Diagnostics, Inc. |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of Raf kinase for treatment of cancer
|
AU2004281151A1
(en)
|
2003-10-16 |
2005-04-28 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted benzazoles and use thereof as inhibitors of Raf kinase
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
US20050165031A1
(en)
|
2003-11-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Urea derivatives as ABL modulators
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
EP1711196A4
(en)
|
2003-12-05 |
2011-09-14 |
Bristol Myers Squibb Co |
INHIBITORS OF TYPE-2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS
|
EP1694331B8
(en)
|
2003-12-09 |
2010-02-24 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Methods for suppressing an immune response or treating a proliferating disorder
|
CA2548571A1
(en)
|
2003-12-10 |
2005-06-30 |
Merck Patent Gmbh |
Diacylhydrazine derivatives
|
CA2548394A1
(en)
|
2003-12-12 |
2005-06-30 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
BRPI0507198A
(pt)
|
2004-01-30 |
2007-06-26 |
Merck Patent Gmbh |
derivados de bisariluréia
|
US20050267060A1
(en)
|
2004-03-19 |
2005-12-01 |
The Penn State Research Foundation |
Combinatorial methods and compositions for treatment of melanoma
|
CN101010315A
(zh)
|
2004-04-30 |
2007-08-01 |
拜耳制药公司 |
用于治疗癌症的取代的吡唑基脲衍生物
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
ATE395905T1
(de)
|
2004-08-27 |
2008-06-15 |
Bayer Pharmaceuticals Corp |
Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
|
US7745446B2
(en)
|
2004-09-06 |
2010-06-29 |
Bayer Schering Pharma Aktiengesellschaft |
Pyrazolo[1,5-c]pyrimidines
|
SG155996A1
(en)
|
2004-09-29 |
2009-10-29 |
Bayer Schering Pharma Ag |
Thermodynamically stable form of bay 43-9006 tosylate
|
NZ554119A
(en)
|
2004-09-29 |
2010-07-30 |
Bayer Schering Pharma Ag |
Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide
|
EP1858877B1
(en)
|
2005-01-14 |
2014-03-12 |
Gilead Connecticut, Inc. |
1,3 substituted diaryl ureas as modulators of kinase activity
|
KR101335932B1
(ko)
|
2005-03-07 |
2013-12-04 |
바이엘 헬스케어 엘엘씨 |
암의 치료를 위한 오메가-카르복시아릴 치환된 디페닐우레아를 포함하는 제약 조성물
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
KR20080018908A
(ko)
|
2005-05-27 |
2008-02-28 |
바이엘 헬스케어 아게 |
암 치료용 디아릴 우레아 화합물 및 pi3, akt 키나제또는 mtor 억제제 (라파마이신)를 포함하는 병용요법
|
CA2609387A1
(en)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Combination therapy comprising diaryl ureas for treating diseases
|
EP1937837A2
(en)
|
2005-07-29 |
2008-07-02 |
Siemens Healthcare Diagnostics Inc. |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
ATE493652T1
(de)
|
2005-08-11 |
2011-01-15 |
Siemens Healthcare Diagnostics |
Quantitative assays für pdgfr-beta- in körperflüssigkeiten
|
US20070066060A1
(en)
|
2005-09-19 |
2007-03-22 |
Taiwan Semiconductor Manufacturing Co., Ltd. |
Semiconductor devices and fabrication methods thereof
|
BRPI0617167B8
(pt)
|
2005-09-21 |
2021-05-25 |
Nycomed Gmbh |
sulfonilpirróis como inibidores de hdac's, seu uso, composição farmacêutica e combinação
|
NZ566073A
(en)
|
2005-09-21 |
2011-08-26 |
4Sc Ag |
Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
|
US20090221010A1
(en)
|
2005-10-21 |
2009-09-03 |
Elting James J |
Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
US20090215835A1
(en)
|
2005-10-31 |
2009-08-27 |
Scott Wilhelm |
Treatment of cancer with sorafenib
|
US20090068146A1
(en)
|
2005-10-31 |
2009-03-12 |
Scott Wilhelm |
Diaryl ureas and combinations
|
CA2628091A1
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
BRPI0618092A2
(pt)
|
2005-11-02 |
2011-08-16 |
Bayer Healthcare Llc |
métodos "in vitro" para monitorar o estado de uma doença, de seleção de terapia e de diagnóstico de cáncer
|
US20100035888A1
(en)
|
2005-11-10 |
2010-02-11 |
Bater Healthcare AG |
Diaryl Urea for Treating Pulmonary Hypertension
|
DK1948176T3
(da)
|
2005-11-10 |
2011-04-18 |
Bayer Schering Pharma Ag |
Diarylurinstoffer til behandling af pulmonær hypertension
|
CN101454668A
(zh)
|
2005-11-14 |
2009-06-10 |
拜耳医药保健有限责任公司 |
癌症预测与预后以及监测癌症治疗的方法
|
CA2629863A1
(en)
|
2005-11-14 |
2007-05-24 |
Scott Wilhelm |
Use of sorafenib for the treatment of cancers with acquired resistance to kit inhibitors
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
CA2631746A1
(en)
|
2005-12-01 |
2007-06-07 |
Bayer Healthcare Llc |
Urea compounds useful in the treatment of cancer
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
WO2007087575A2
(en)
|
2006-01-24 |
2007-08-02 |
University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
JP5349056B2
(ja)
|
2006-02-22 |
2013-11-20 |
4エスツェー アクチェンゲゼルシャフト |
Eg5キネシンモジュレーターとしてのインドロピリジン類
|
KR20080103977A
(ko)
|
2006-02-22 |
2008-11-28 |
4에스체 악티엔게젤샤프트 |
Eg5 키네신 조절자로서 인돌로피리딘
|
WO2007109571A2
(en)
|
2006-03-17 |
2007-09-27 |
Prometheus Laboratories, Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
WO2007123722A2
(en)
|
2006-03-31 |
2007-11-01 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
JP2009538317A
(ja)
|
2006-05-26 |
2009-11-05 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌治療のための置換ジアリールウレアを用いた薬物の組み合わせ
|
MX2009004861A
(es)
|
2006-11-09 |
2009-05-21 |
Abbott Gmbh & Co Kg |
Forma de dosificacion farmaceutica para la administracion oral de inhibidor de tirosina quinasa.
|
EP2111401B1
(en)
|
2006-12-20 |
2011-02-16 |
Bayer HealthCare, LLC |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
|
EP2134677B1
(en)
|
2006-12-20 |
2011-10-12 |
Bayer HealthCare LLC |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1h-pyrazol-5-yl}carbamoyl)-amino]-3-chlorophenoxy}-n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
|
JP5885012B2
(ja)
|
2007-01-19 |
2016-03-15 |
バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC |
Kit阻害剤に対して獲得した抵抗性を有する癌の処置
|
EP2195286A2
(en)
|
2007-09-10 |
2010-06-16 |
Cipla Limited |
Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
|
WO2009054004A2
(en)
|
2007-10-22 |
2009-04-30 |
Natco Pharma Limited |
Process for the preparation of sorafenib
|
EP2341777B1
(en)
|
2008-11-07 |
2015-01-21 |
NovaBay Pharmaceuticals, Inc. |
Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
|
CN102111718B
(zh)
|
2009-12-28 |
2014-12-17 |
深圳市齐创美科技有限公司 |
电子信息分发***及方法
|
JP5821626B2
(ja)
|
2011-12-27 |
2015-11-24 |
富士ゼロックス株式会社 |
画像形成装置及びプログラム
|